Synthetic opioids continue to concern European drug agencies. A new report states that ‘polydrug’ use is leading to new health risks. Data on cannabis since Germany’s legalization, however, is still sparse.
Full report: https://www.emcdda.europa.eu/system/files/documents/2024-06/edr-2024-compiled-pdf-11.06.2024.pdf
Archived version: https://archive.ph/a35Wz
You must log in or register to comment.